title: MRI of localized prostate cancer: coming of age in the PSA era.
abstract: Prostate cancer is the most common cancer among American men. It varies widely     in aggressiveness, ranging from completely indolent to highly aggressive.     Currently, predicting the natural history of a particular tumor and deciding on     the appropriate treatment, which might include active surveillance, surgery,     radiation or hormonal therapies, are based on the condition and age of the     patient as well as the presumed stage of the disease. Imaging plays an important     role in staging localized prostate cancer. Magnetic resonance imaging (MRI) best     depicts the zonal anatomy, with a superior soft tissue resolution providing     better results for tumor localization, monitoring, and local staging.     Previously, the major function of prostate MRI has been in staging, and this     role remains important. In this article, we introduce the reader to the     expanding roles that MRI plays in the management of localized prostate cancer.
authors.affiliation: Molecular Imaging Program, National Cancer Institute, NIH, Bethesda, MD, USA.
authors.forename: Barış
authors.initials: B
authors.lastname: Türkbey
authors.forename: Marcelino
authors.initials: M
authors.lastname: Bernardo
authors.forename: Maria J
authors.initials: MJ
authors.lastname: Merino
authors.forename: Bradford J
authors.initials: BJ
authors.lastname: Wood
authors.forename: Peter A
authors.initials: PA
authors.lastname: Pinto
authors.forename: Peter L
authors.initials: PL
authors.lastname: Choyke
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003663:Decision Trees; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000473:pathology*
chemical_list: D017430:Prostate-Specific Antigen